| # | Drug | Count |
|---|---|---|
| 0 | BEVACIZUMAB | 40 |
| 1 | VORICONAZOLE | 18 |
| 2 | VORICONAZOLE INJECTION | 18 |
| 3 | CIPROFLOXACIN | 11 |
| 4 | CIPROFLOXACIN HYDROCHLORIDE | 11 |
| 5 | CIPROFLOXACIN TABLETS | 11 |
| 6 | CIPROFOLXACIN | 11 |
| 7 | PROPARACAINE HYDROCHLORIDE | 11 |
| 8 | POVIDONE-IODINE | 8 |
| 9 | ACETAMINOPHEN | 7 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PROPARACAINE HYDROCHLORIDE | 11 | 0.0206 |
| 1 | TETRACAINE HYDROCHLORIDE | 1 | 0.0075 |
| 2 | THROMBIN HUMAN AND FIBRINOGEN | 1 | 0.0030 |
| 3 | CANGRELOR | 1 | 0.0025 |
| 4 | LIDOCAINE HCL 3% | 1 | 0.0022 |
| 5 | POVIDONE-IODINE | 8 | 0.0019 |
| 6 | EPTIFIBATIDE | 1 | 0.0013 |
| 7 | DINUTUXIMAB | 1 | 0.0012 |
| 8 | ANTIHEMOPHILIC FACTOR/VON WILLEBRAND FACTOR COMPLEX (HUMAN) | 1 | 0.0009 |
| 9 | BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE, AND TETRACYCLINE HYDROCHLORIDE | 1 | 0.0009 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Antiseptic [EPC] | 8 | 0.0018 |
| 1 | Human Blood Coagulation Factor [EPC] | 1 | 0.0012 |
| 2 | Glycolipid Disialoganglioside-directed Antibody [EPC] | 1 | 0.0009 |
| 3 | alpha-1 Adrenergic Agonist [EPC] | 1 | 0.0002 |
| 4 | beta Lactamase Inhibitor [EPC] | 1 | 0.0002 |
| 5 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 40 | 0.0002 |
| 6 | Azole Antifungal [EPC] | 18 | 0.0001 |
| 7 | Fluoroquinolone Antibacterial [EPC] | 12 | 0.0001 |
| 8 | Parenteral Iron Replacement [EPC] | 1 | 0.0001 |
| 9 | Stimulant Laxative [EPC] | 1 | 0.0001 |